4 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide: new trials by email Literature Review of 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide trials Research Report on 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SarCNU in Treating Patients With Recurrent Malignant Glioma SarCNU - Brain and Central Nervous System Tumors | Phase 2 | Completed | NCIC Clinical Trials Group | 10 | 2002-01-10 | 2020-04-06 |
| SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer SarCNU - Colorectal Cancer | Phase 2 | Completed | NCIC Clinical Trials Group | 18 | 2001-10-30 | 2020-04-09 |
| Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors SarCNU, pharmacological study, laboratory biomarker analysis - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | National Cancer Institute (NCI) | 46 | 1999-08-01 | 2013-02-01 |
| Chemotherapy in Treating Patients With Advanced Solid Tumors SarCNU - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Jewish General Hospital | 1999-01-01 | 2013-03-26 |
Astrocytoma (1) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Glioblastoma (1) · Gliosarcoma (1) · Rectal Neoplasms (1)
NCIC Clinical Trials Group (2) · Jewish General Hospital (1) · National Cancer Institute (NCI) (1)
Canada (3) · United States (1)
Lawrence C. Panasci, MD (2) · Joseph Eder (1) · Ralph PW Wong, MD, FRCPC (1)
PMID 12525514, PMID 16034522, PMID 16502354
U01CA062490 (1)